Literature DB >> 25266026

Therapeutic approaches to gastroesophageal junction adenocarcinomas.

Rachel L G M Blom1, Tatiana Bogush, Björn L D M Brücher, Andrew C Chang, Mikhail Davydov, Evgeny Dudko, Trevor Leong, Boris Polotsky, Paul E Swanson, Peter S N van Rossum, Jelle P Ruurda, Xavier Sagaert, Sergei Tjulandin, Marie-Celine Schraepen, Meindert N Sosef, Richard van Hillegersberg.   

Abstract

The following, from the 12th OESO World Conference: Cancers of the Esophagus, includes commentaries on the distinction between adenocarcinomas above, below, or within the gastroesophageal junction; combined modality therapy; tumor markers for use in personalized medicine; PET-CT and endoscopic biopsies in the evaluation of response to neoadjuvant chemoradiation therapy; a standardized grading system for tumor regression in squamous cell cancer and adenocarcinoma; the experimental basis for new approaches to medical treatment; the criteria measuring response in esophageal cancer; and the impact of novel imaging on staging and response assessment.
© 2014 New York Academy of Sciences.

Entities:  

Keywords:  OESO; PET-CT; combined modality therapy; gastroesophageal junction; tumor grading; tumor markers; tumor regression

Mesh:

Substances:

Year:  2014        PMID: 25266026     DOI: 10.1111/nyas.12532

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  1 in total

1.  Neoadjuvant vs. adjuvant treatment of Siewert type II gastroesophageal junction cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry.

Authors:  Joseph A Miccio; Oluwadamilola T Oladeru; Jie Yang; Yaqi Xue; Minsig Choi; Yue Zhang; Hannah Yoon; Samuel Ryu; Alexander M Stessin
Journal:  J Gastrointest Oncol       Date:  2016-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.